| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $36.2M | -5.5% | -10.6% |
| Cost of Revenue | $26.6M | +3.9% | -1.6% |
| R&D Expense | $6.1M | -4.9% | -6.8% |
| SG&A Expense | $6.1M | -47.1% | -57.0% |
| Operating Income | -$7.0M | +39.9% | +40.1% |
| Pre-tax Income | -$6.2M | +43.0% | +37.3% |
| Income Tax | $56K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $100.0M | -4.8% | -38.8% |
| Accounts Receivable | $52.2M | -10.9% | -17.2% |
| Inventory | $28.1M | -15.8% | -21.9% |
| Current Assets | $201.5M | -7.4% | -29.3% |
| Total Assets | $335.8M | -5.1% | -25.1% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$29.2M | — | — |
| Capital Expenditures | $3.6M | — | — |
| Investing Cash Flow | -$6.9M | — | — |
| Financing Cash Flow | -$7.0M | — | — |
| Free Cash Flow | -$32.8M | — | — |
| +269.7% |
| +211.1% |
| Net Income | -$6.3M | +42.3% | +36.8% |
| EPS (Basic) | -$0.03 | +50.0% | +40.0% |
| EPS (Diluted) | -$0.03 | +50.0% | +40.0% |
| $72.6M |
| -9.3% |
| -15.5% |
| Total Liabilities | $101.4M | -11.9% | -29.3% |
| Stockholders' Equity | $234.4M | -1.9% | -23.2% |